Once again this year, BIOGENERA S.p.A. participated in Bio Europe Spring 2025, the leading European conference dedicated to the biotech and pharmaceutical sectors, held in Milan from March 17th to 19th, 2025.
Organized by the EBD Group, Bio Europe is one of the most important business development events for the life sciences community. The 2025 edition gathered over 5,000 industry professionals, with more than 30,000 one-to-one meetings scheduled, involving start-ups, established biotech companies, global pharmaceutical groups, and international investors.
BIOGENERA joined the event with the goal of strengthening relationships with pharmaceutical and biotech companies, as well as with investment funds, to explore strategic partnerships and licensing agreements related to its proprietary drug pipeline and MyGenera™ platform, dedicated to the design of innovative anti-gene therapies.
Participation in Bio Europe 2025 represents an important step in Biogenera’s internationalization strategy and development in the field of advanced therapies.
English 
Italian